None
Quote | MGC Pharmaceuticals Ltd (OTCMKTS:MGCLF)
Last: | $0.2675 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.2675 |
High: | $0 |
Low: | $0 |
Volume: | 2 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | MGC Pharmaceuticals Ltd (OTCMKTS:MGCLF)
--News Direct-- Argent BioPharma managing director and CEO Roby Zomer speaks to Proactive's Stephen Gunnion following the company's rebranding from MGC Pharmaceuticals, alongside a comprehensive restructuring. Zomer explained the shift marks a refined focus on the pharmaceutical s...
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation PR Newswire Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma's Innovative Drug Portfolio LONDON , Feb. 13, 2024 /PRNe...
Message Board Posts | MGC Pharmaceuticals Ltd (OTCMKTS:MGCLF)
Subject | By | Source | When |
---|---|---|---|
yeah... you're correct, but will it be undervalued | john1311 | investorshub | 02/19/2021 8:39:41 PM |
Current market cap , around 215 m usd | MADDSTACKER | investorshub | 02/18/2021 2:40:35 PM |
Still very undervalued | MADDSTACKER | investorshub | 02/18/2021 2:36:33 PM |
up 37% in Australia today | john1311 | investorshub | 02/18/2021 9:57:24 AM |
This may be possible, they do stuff with | syntax error | investorshub | 02/17/2021 7:47:15 PM |
News, Short Squeeze, Breakout and More Instantly...
MGC Pharmaceuticals Ltd Company Name:
MGCLF Stock Symbol:
OTCMKTS Market:
--News Direct-- Argent BioPharma managing director and CEO Roby Zomer speaks to Proactive's Stephen Gunnion following the company's rebranding from MGC Pharmaceuticals, alongside a comprehensive restructuring. Zomer explained the shift marks a refined focus on the pharmaceutical s...
MGC Pharma Rebrands as Argent BioPharma in Strategic Transformation PR Newswire Embracing Comprehensive Restructuring for a New Biopharmaceutical Era Continuing the Development of MGC Pharma's Innovative Drug Portfolio LONDON , Feb. 13, 2024 /PRNe...
(NewsDirect) MGC Pharmaceuticals Ltd CEO and Managing Director Roby Zomer speaks to Thomas Warner from Proactive London following the completion of a share consolidation and capital raise. With these restructuring initiatives completed, Zomer shares his enthusiasm for the future of th...